Bellicum Pharmaceuticals, Inc.
BLCM
BLCM was delisted on the 1st of June, 2023.
71 hedge funds and large institutions have $340M invested in Bellicum Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 18 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
29% more funds holding
Funds holding: 55 → 71 (+16)
13% more capital invested
Capital invested by funds: $300M → $340M (+$39.1M)
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
94% less call options, than puts
Call options by funds: $23K | Put options by funds: $394K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$11.4M |
| 2 |
JP Morgan Chase
New York
|
+$8.88M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$6.17M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.66M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$10.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.92M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.88M |
| 4 |
Morgan Stanley
New York
|
-$2.82M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.5M |
BLCM Hedge Fund Activity: Q1 2015 in Review
71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q1 2015, worth a combined $340M — up 13% from $300M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new BLCM positions and 18 closed out — a net gain of 16 holders — while 11 added to existing stakes and 17 trimmed.
The largest buyer was Franklin Resources, adding an estimated $11.4M. The largest seller was Redmile Group, cutting an estimated $10.1M.
- 71 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q1 2015, up from 55 in Q4 2014.
- Funds reported $340M of Bellicum Pharmaceuticals, Inc. stock for Q1 2015, up 13% quarter-over-quarter.
- 34 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q1 2015 and 18 closed out, a net change of +16 holders.
- The largest Bellicum Pharmaceuticals, Inc. buyer in Q1 2015 was Franklin Resources, an estimated $11.4M added.
- The largest Bellicum Pharmaceuticals, Inc. seller in Q1 2015 was Redmile Group, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2015.